trifluoromethylpyridine

structure in first source

Also Known As:

TFM-pyridine

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 09/01/2009 - "The new trifluoromethylpyridine derivatives were evaluated for their anticancer activity toward human cancer cell lines by the National Cancer Institute (NCI). "
2.	Chromosome Aberrations (Chromosome Abnormalities) 01/01/1993 - "All three compounds were also clastogenic as demonstrated by increases in chromosome aberrations and micronuclei (except for 2-chloro-5-trifluoromethylpyridine which did not induce micronuclei either with or without activation)."